Abstract
Introduction

24
p-hydroxybenzoate (PHBA) is an important building block of liquid crystal polymers (LCPs) 25 in the chemical polymer industry [1] . LCPs are special chemical products that are used for 26 electronics and fiber industries. The demand for LCPs is increasing, especially in the 27 electronics industry. Moreover, PHBA is the base material of preservatives in the cosmetic 28 and pharmaceutical industries. Although organic synthetic chemistry can synthesize PHBA, it 29 is derived from non-renewable petroleum resources and its synthesis is energy intensive. Here, 30 we attempted to produce PHBA from benzoate in recombinant E. coli expressing fungal 31 cytochrome P450 (CYP53A15).
32
P450 is a member of the ubiquitous heme-thiolate monooxygenase family, which is fungi, as they play crucial roles in detoxification and the degradation of plant defensive 5 phenolic compounds (e.g., benzoate) [6, 7] . Benzoate is hydroxylated to PHBA by CYP53 6 catalysis and is then metabolized through the β-ketoadipate pathway to produce intermediates, 7 which enter the TCA cycle and are utilized as carbon sources [8, 9] . The CYP53A15 enzyme 8 is produced by the filamentous fungus Cochliobolus lunatus, an opportunistic plant and 9 human pathogen. The enzymatic properties of purified, recombinant CYP53A15 (expressed 10 by E. coli) have been characterized. CYP53A15 can hydroxylate benzoate to either PHBA or 11 3,4-dihydroxybenzoate, depending on which endogenous CPR it is combined with. Also, a 12 mutant C. lunatus strain deficient in CYP53A15 has been shown to be more susceptible to 13 benzoate than the wild type strain, demonstrating an essential role of this enzyme in 14 detoxification of a plant defensive compound [6, 7] . Waltham, MA), and obtained as a pMK-RQ-CYP53A15 plasmid; these nucleotide 8 modifications add SmaI (CCCGGG) and SalI (GTCGAC) recognition sites (Fig. 1A) . The 9 pMK-RQ-CYP53A15 plasmid was digested with SmaI and SalI and ligated into five modified 10 pCWR vectors for co-expression of P450 and CPR (Fig. 1B) HCl and 10 μl of 10 mM 8-MOP as an internal standard. A 500-μl aliquot of the mixture was 12 added to the same volume of methanol. After thorough agitation, the mixture was centrifuged CYP53A15 cDNA into expression vectors (Fig. 1A) . The membrane-bound P450 expression 7 vectors used in this study (pCWRm1A2N, -rab2C3N, -r2C11N, -m2C29N, and -h2E1N the transformed cells showed a characteristic peak at 450 nm in their CO-difference spectra
17
( Fig. S1 ), they all produced PHBA (Fig. 2, Fig. S2 ). This finding suggests the production of and 30°C (Fig. 3A, Fig. S3 ). PHBA production was detected under all of the tested induction 31 temperatures (Fig. 3B) and the PHBA productivities 2.5-times those of the E. coli JM109 cells (Fig. 4) . These results
28
suggest that the E. coli BW25113 and ΔgcvR strains are more suitable for PHBA production.
29
The P450 contents and PHBA productivities of the other E. coli single-gene knockout strains,
30
ΔcpxA and ΔglnL, were lower than those of E. coli JM109 (data not shown). Also, we 31 detected no significant difference in these variables between E. coli BW25113 and ΔgcvR and 32 thus there was no effects on P450 activity by the single-gene knockouts. These findings might 33 be due to the different redox partners, which were putidaredoxin and putidaredoxin reductase,
34
but not CPR, in the case of CYP154A1, for P450 under each experimental condition [19] .
35
We also examined CYP53A15 expression in various growth media: total nutrient 36 content in the tested media decreases in the order of SB>TB>2×YT>LB. In E. coli BW25113
37
and ΔgcvR cells, P450 contents were the highest in TB medium, whereas PHBA productivity 38 8 was the highest in 2×YT medium (Fig. 5) Optimization of the reaction conditions for PHBA production 18 First, we identified the optimal temperature: PHBA productivity at 25°C was 1.2-times that at 19 the 30°C used above experiments (Fig. 6A ). This 25C temperature was similar to the optimal 20 growth temperature of C. lunatus [6] and was used for all subsequent experiments.
21
To maximize cost-effectiveness, we estimated the conversion ratio from benzoate to
22
PHBA under various substrate concentrations. Under the reaction conditions used, most of the 23 benzoate was not reacted when using a substrate concentration of 2 mM, whereas the 24 benzoate was totally converted to PHBA when a substrate concentration of 0.1 mM was used.
25
The conversion ratios at the 0.2 and 0.5 mM substrate concentrations were 58 ± 3 and 27 ± 26 1%, respectively (Fig. 6B) . We aimed to completely convert 0.2 and 0.5 mM benzoate by 27 further optimization of the reaction conditions. converted, while the conversion ratio at the 0.5 mM substrate concentration was increased to 33 45 ± 1% (Fig. 6C ).
34
We hypothesized that the low conversion ratio at the substrate concentration of 0.5 35 mM was caused by limited NADPH regeneration. Therefore, we attempted to improve the 36 conversion ratio by increasing the E. coli cell concentration in the reaction solution. By this 37 approach, the conversion ratio reached 90 ± 2% at OD = 2.5 (Fig. 6D) transformed with pCWRrab2C3N-53A15) (Fig. 2) . In a previous study, in yeast cells . Thus, our E. coli bioconversion system is more efficient at producing PHBA than 8 the previously described yeast system.
9
Here we were successful in the p-specific hydroxylation of benzoate by using a 10 CYP53A15 and human CPR combination. As described above, CYP53A15 produces 11 alternative reaction products depending on its combination with CPR [6]. As reaction 12 products, our E. coli bioconversion system method does not produce o-or m-hydroxybenzoate, 13 nor dihydroxybenzoate. Therefore, the CYP53A15 and human CPR used here are suitable for
14
PHBA production. Moreover, we propose that PHBA productivity could be further improved further increase PHBA productivity.
30
In summary, we constructed a bioconversion system to PHBA system in E. the Pro-Gly site, respectively. In our expression system, the bases encoding the initial 36 34 amino acids of CYP53A15, which correspond to the transmembrane region, were deleted.
35
m1A2, mouse CYP1A2; rab2C3, rabbit CYP2C3; r2C11, rat CYP2C11; m2C29, mouse 36 CYP29; and h2E1, human CYP2E1. 
